Asthma monitoring device from iSonea set for EU approval

09/6/2013 | BioSpectrum Asia

Device manufacturer iSonea believes it is on the cusp of securing the CE mark to market its asthma monitoring device called the AirSonea Wheeze Monitor. The company is working to potentially launch the device in Europe after an anticipated U.S. release of the product next year. The company also is preparing to release the product this month in Australia.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC